Q4 2024 Earnings Call Transcript March 25, 2025 Corvus Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.18 EPS, expectations were $-0.12. Operator: Good afternoon, everyone.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback